Atezolizumab in Advanced Bladder Cancer Real-World Immunotherapy Dataset for AI LLM
Bladder Cancer Real-World Immunotherapy Dataset for AI LLM Patients with advanced bladder cancer treated with Atezolizumab have shown significantly better response rates and survival than historical controls receiving second-line chemotherapy. The toxicity profile is also favorable—making it one of the most impactful developments in uro-oncology in the past decade. But the opportunity doesn’t stop there. … Read more